North America Cord Blood Banking Services Market Size to 2028

North America Cord Blood Banking Services Market Size, Share & Industry Trends Analysis Report By Component (Cord Tissue and Cord Blood), By Storage Services (Private Cord Blood Banks and Public Cord Blood Banks), By Application, By Country and Growth Forecast, 2022 - 2028

Published Date: November-2022 | Number of Pages: 58 | Format: PDF | Report ID: KBV-20804

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the North America Cord Blood Banking Services Market

Market Report Description

The North America Cord Blood Banking Services Market would witness market growth of 11.7% CAGR during the forecast period (2022-2028).

Cord blood is the blood that is still present in the placenta and umbilical cord after a baby is delivered. Similar to those found in the bone marrow, it is abundant in blood stem cells, which can be employed to treat a variety of malignancies, immunological deficiencies, and genetic abnormalities. A cord blood transplant is used to treat a variety of significant illnesses, including bone marrow failure, sickle cell anemia, immunodeficiency, thalassemia, and metabolic problems. Blood cancers including leukemia and lymphoma are also treated with this procedure. Cord blood banking is the process of obtaining cord blood, extracting its stem cells and immune system cells, and cryogenically storing them for use in the future.

The stem cells in umbilical cord blood are abundant. Stem cells are useful because they aid in the treatment of a variety of fatal diseases. The majority of healthy individuals have no trouble producing stem cells. Unfortunately, due to a serious illness or medical condition, some people don't produce enough healthy stem cells. For certain people, stem cells from cord blood may even save their lives. These stem cells can be gathered and stored in cord blood banks. Medical professionals employ cord blood stem cells for transplantation in ill patients or for scientific studies.

The FDA's regulations do not require prior permission for the use of cord blood that has been kept for individual use or to be used by first- or second-degree relatives and meet other requirements. Other FDA criteria, such as establishment registration and listing, infectious disease screening and testing of donors (except when utilized for the original donor) and compliance with current good tissue practice regulations, still apply to private cord banks. Thus, the cord blood banking services market would expand in the North America region.

The US market dominated the North America Cord Blood Banking Services Market by Country in 2021; thereby, achieving a market value of $739.3 million by 2028. The Canada market is experiencing a CAGR of 13.9% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 13.6% during (2022 - 2028).

Based on Component, the market is segmented into Cord Tissue and Cord Blood. Based on Storage Services, the market is segmented into Private Cord Blood Banks and Public Cord Blood Banks. Based on Application, the market is segmented into Diabetes, Cancer Disease, Blood Disease, Immune Disorders, Metabolic Disorders, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Global Cord Blood Banking Services Market is Predict to reach $2.9 Billion by 2028, at a CAGR of 13.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AMAG Pharmaceuticals, Inc., Americord Registry LLC, StemCyte, Inc., Cordlife Group Limited, cordvida, Cryo-Cell International, Inc., CryoHoldco de LatinoAmérica and Vita 34 AG

Scope of the Study

Market Segments Covered in the Report:

By Component

  • Cord Tissue
  • Cord Blood

By Storage Services

  • Private Cord Blood Banks
  • Public Cord Blood Banks

By Application

  • Diabetes
  • Cancer Disease
  • Blood Disease
  • Immune Disorders
  • Metabolic Disorders
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • AMAG Pharmaceuticals, Inc.
  • Americord Registry LLC
  • StemCyte, Inc.
  • Cordlife Group Limited
  • cordvida
  • Cryo-Cell International, Inc.
  • CryoHoldco de LatinoAmérica
  • Vita 34 AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Cord Blood Banking Services Market Report 2022-2028

Europe Cord Blood Banking Services Market Report 2022-2028

Asia Pacific Cord Blood Banking Services Market Report 2022-2028

LAMEA Cord Blood Banking Services Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities